New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 9, 2013
10:45 EDTVVUS, VVUSSummer Street's biotech analyst holds an analyst/industry conference call
Analysts discuss the expected patent life of Vivus (VVUS) Qsymia on an Analyst/Industry conference call to be held on October 9 at 11 am.
News For VVUS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 3, 2015
06:30 EDTVVUSVIVUS price target lowered to $2.30 from $3 at WallachBeth
WallachBeth analyst Bob Ai lowered his price target for VIVUS for $2.30 after the company announced plans to cut its sales force by one-half, to 50, in order to achieve its new corporate goal of operating cash flow being neutral or positive by the end of 2016. This is not the best move for long-term shareholders, Ai tells investors in a research note. The sales force reduction may result in a significant sales decline, the analyst believes. He keeps a Hold rating on VIVUS.
July 30, 2015
19:08 EDTVVUSVIVUS announces restructuring plan, will reduce headcount
Subscribe for More Information
16:02 EDTVVUSVIVUS reports Q2 EPS (19c), consensus (24c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use